BioLegend 554306 Recombinant Human MMP-2 (carrier-free)

BioLegend 554306 Recombinant H

uman MMP-2 (carrier-free)
收藏
  • 询价
  • BioLegend
  • 554306
  • BioLegend
  • 2025年11月08日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 技术资料
    • 库存

      99

    • 英文名

      BioLegend 554306 Recombinant Human MMP-2 (carrier-free)

    • 供应商

      北京云肽生物科技有限公司

    BioLegend 554306 Recombinant Human MMP-2 (carrier-free)

    北京云肽生物科技有限公司作为 BioLegend 的特约经销商,为广大客户提供原装正品,货期短,折扣好的服务准则。

    美国 BioLegend 公司位于美国加州,致力于为生物医药研究的各个前沿领域提供高质量的抗体及其它相关试剂。BioLegend 虽然成立的时间不长,但它聚集了一批来自 PharMingen 公司的专业人士,建立了一支具有雄厚技术背景的专业队伍。通过其自身的先天优势,以及与世界知名实验室和研究所的良好合作关系,以合理的价格为广大客户提供高质量的免疫学和细胞生物学产品。
    BioLegend 公司以其专业技术力量为保证,提供各种质量卓越的产品,并不断地开发新产品,以满足飞速发展的生命科学研究的需要。

    BioLegend 554306 Recombinant Human MMP-2 (carrier-free)
    产品简介:
    产品品牌:BioLegend
    产品货号:554306
    产品名称:BioLegend 554306 Recombinant Human MMP-2 (carrier-free)
    产品规格: 100 µg

    产品说明:
    Regulatory Status  RUO
    Other Names
    Matrix metallopeptidase 2, Gelatinase A, MMP2, GelA, Clg4a

    描述
    基质金属蛋白酶2,也称明胶酶A,是基质金属蛋白酶家族蛋白(MMPs)的成员。MMPs是结构相关的含锌酶,在胚胎发育、繁殖和组织重塑等正常生理过程以及关节炎和转移等疾病过程中降解细胞外基质和结缔组织蛋白。MMP-2由激活时被切割的前结构域、含有锌结合位点的催化结构域、纤连蛋白样结构域(在底物靶向中起作用)和羧基末端(血红素样重复序列)结构域组成。MMP-2的激活需要蛋白水解处理:首先,膜型MMP(MT1-MMP)和金属蛋白酶组织抑制剂2的复合物将pro-MMP-2从细胞外环境募集到细胞表面;其次,MMP-2被活性MT1-MMP和随后的自催化切割激活。MMP-2的底物包括IV型胶原、聚集蛋白聚糖、连接蛋白、去胶蛋白、纤连蛋白以及X型和XI型胶原,所有这些都是关节软骨基质的成分。重要的是,MMP-2分泌在几种类型的人类癌症中升高,其表达升高与预后不良有关。MMP-2基因突变与Torg-Winchester综合征、多中心骨溶解、关节炎综合征以及可能的瘢痕疙瘩有关。MMP-2缺陷小鼠表现出轻微的生长延迟、新生血管减少、肿瘤进展迟缓、对过敏原的哮喘反应过度以及乳腺分支形态发生受损。
    MMP-2, also named gelatinase A, is a member of matrix metalloproteinase family proteins (MMPs). MMPs are structurally related, zinc-containing enzymes that degrade the extracellular matrix and connective tissue proteins in normal physiological processes such as embryonic development, reproduction, and tissue remodeling as well as in disease processes such as arthritis and metastasis. MMP-2 consists of a prodomain, which is cleaved upon activation, a catalytic domain containing the zinc binding site, a fibronectin-like domain (that plays a role in the substrate targeting), and a carboxyl-terminal (hemopexin-like repeats) domain. Activation of MMP-2 requires proteolytic processing: first, a complex of membrane type 1 MMP (MT1-MMP) and tissue inhibitor of metalloproteinase 2 recruits pro-MMP-2 from the extracellular milieu to the cell surface; second, MMP-2 is activated by active MT1-MMP and subsequent autocatalytic cleavage. Substrates of MMP-2 include type IV collagen, aggrecan, link protein, decorin, fibronectin, and type X and XI collagens, all of which are components of the articular cartilaginous matrix. Importantly, MMP-2 secretion is elevated in several types of human cancers and its elevated expression has been associated with a poor prognosis. Mutations in the MMP-2 gene are associated with Torg-Winchester syndrome, multicentric osteolysis, arthritis syndrome, and possibly keloids. MMP-2 deficient mice exhibit slightly delayed growth, reduced neovascularization, retarded tumor progression, an exaggerated asthma response to allergens, and impaired branching morphogenesis of the mammary gland.

    Product Details
    Source
    Human MMP-2, amino acids (Ala30-Cys660) (Accession# NP_004521.1) with a C-terminal His tag and a linker sequence, was expressed in 293E cells.

    Molecular Mass
    This 652 amino acid recombinant protein has a predicted molecular mass of approximately 73.2 kD. The protein migrates at about 73 kD in DTT-reducing conditions and about 73 kD in non-reducing conditions by SDS-PAGE.The predicted N-terminal amino acid is Ala.

    Purity
    >95%, as determined by Coomassie stained SDS-PAGE.
    Formulation
    0.22 µm filtered protein solution is in TCN (25 mM TRIS, 5 mM CaCl2, 150 mM NaCl, pH 7.5).

    Endotoxin Level
    Less than 1.0 EU per µg of protein as determine by the LAL method
    Concentration
    10 and 25 µg sizes are bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.

    Storage & Handling
    Unopened vial can be stored at -20°C or -70°C for six months. For maximum results, quick spin vial prior to opening. Avoid repeated freeze/thaw cycles.

    Activity
    Human MMP-2 cleaves the modified fluorogenic peptide Mca-PLGL-Dpa-AR-NH2 with an activity above 1100 pmol/min/µg.
    Application   Bioassay

    Application Notes
    Human MMP-2 at a concentration 100 µg/mL was activated for at least 1 h at 37°C in the presence of 1 mM APMA to produce activated MMP-2. The final assay condition was 10 ng of activated MMP-2 and 10 µM of substrate. Reaction was read at excitation and emission of 320 nm and 405 nm, respectively, in kinetic mode for 5 min.
     
    This protein is in the latent form and needs to be activated for bioassay.

    Antigen Details
    Structure   Monomer
    Distribution
    MMP-2 is expressed by fibroblasts, endothelial cells, alveolar epithelial cells, and macrophages.

    Function
    Degradation of ECM and connective tissue proteins, angiogenesis, tissue remodeling, cancer metastasis and MMP-2 secretion is elevated in several types of cancers.
    Ligand/Receptor    TIMPs, CCL7, thrombospondin 1.
    Bioactivity
    Human MMP-2 cleaves the peptide substrate Mca-PLGL-Dpa-AR-NH2.

    Biology Area
    Angiogenesis, Cell Adhesion, Cell Biology, Neuroinflammation, Neuroscience, Stem Cells
    Molecular Family    Enzymes and Regulators

    以下是 BioLegend 品牌部分产品,如需其他产品请联系本公司销售。
    BioLegend 356926 APC/Cyanine7 anti-human CD185 (CXCR5)  J252D4 100 tests
    BioLegend 356927 PE/Dazzle™ 594 anti-human CD185 (CXCR5)     J252D4 25 tests
    BioLegend 356928 PE/Dazzle™ 594 anti-human CD185 (CXCR5)     J252D4 100 tests
    BioLegend 356930 Brilliant Violet 605™ anti-human CD185 (CXCR5)     J252D4 100 tests
    BioLegend 356932 Biotin anti-human CD185 (CXCR5)    J252D4 100 ug
    BioLegend 356933 Brilliant Violet 711™ anti-human CD185 (CXCR5)     J252D4 25 tests
    BioLegend 356934 Brilliant Violet 711™ anti-human CD185 (CXCR5)     J252D4 100 tests
    BioLegend 356941 Brilliant Violet 750™ anti-human CD185 (CXCR5)     J252D4 25 tests
    BioLegend 356942 Brilliant Violet 750™ anti-human CD185 (CXCR5)     J252D4 100 tests
    BioLegend 356946 APC/Fire™ 750 anti-human CD185 (CXCR5)  J252D4 100 tests
    BioLegend 356954 PE/Fire™ 700 anti-human CD185 (CXCR5)    J252D4 100 tests
    BioLegend 356956 APC/Fire™ 810 anti-human CD185 (CXCR5)  J252D4 100 tests
    BioLegend 357101 Purified anti-human CD77     5B5      25 ug
    BioLegend 357205 PE anti-human CD192 (CCR2)     K036C2     25 tests
    BioLegend 357206 PE anti-human CD192 (CCR2)     K036C2     100 tests
    BioLegend 357208 APC anti-human CD192 (CCR2)   K036C2     100 tests
    BioLegend 357210 Brilliant Violet 421™ anti-human CD192 (CCR2) K036C2     100 tests
    BioLegend 357211 PE/Cyanine7 anti-human CD192 (CCR2) K036C2     25 tests
    BioLegend 357212 PE/Cyanine7 anti-human CD192 (CCR2) K036C2     100 tests
    BioLegend 357217 Brilliant Violet 510™ anti-human CD192 (CCR2) K036C2     25 tests
    BioLegend 357219 APC/Cyanine7 anti-human CD192 (CCR2)    K036C2     25 tests
    BioLegend 357220 APC/Cyanine7 anti-human CD192 (CCR2)    K036C2     100 tests
    BioLegend 554306 Recombinant H

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    北京云肽生物科技有限公司
    2025年11月10日询价
    ¥3371
    谱析(上海)生物科技有限公司
    2025年07月10日询价
    ¥7805
    北京智杰方远科技有限公司
    2025年07月11日询价
    ¥6549
    西宝生物科技(上海)股份有限公司
    2025年07月01日询价
    BioLegend 554306 Recombinant Human MMP-2 (carrier-free)
    询价